AVDL
Lazard Asset Management’s Avadel Pharmaceuticals AVDL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-12,166
| Closed | -$111K | – | 2298 |
|
|
2023
Q1 | $111K | Sell |
12,166
-36,930
| -75% | -$337K | ﹤0.01% | 1493 |
|
|
2022
Q4 | $351K | Sell |
49,096
-95,861
| -66% | -$685K | ﹤0.01% | 1185 |
|
|
2022
Q3 | $726K | Buy |
144,957
+2,380
| +2% | +$11.9K | ﹤0.01% | 1038 |
|
|
2022
Q2 | $347K | Sell |
142,577
-3,565
| -2% | -$8.68K | ﹤0.01% | 1174 |
|
|
2022
Q1 | $998K | Sell |
146,142
-11,495
| -7% | -$78.5K | ﹤0.01% | 998 |
|
|
2021
Q4 | $1.27M | Buy |
157,637
+98,965
| +169% | +$799K | ﹤0.01% | 977 |
|
|
2021
Q3 | $574K | Buy |
58,672
+23,702
| +68% | +$232K | ﹤0.01% | 1151 |
|
|
2021
Q2 | $235K | Hold |
34,970
| – | – | ﹤0.01% | 1199 |
|
|
2021
Q1 | $316K | Buy |
34,970
+5,110
| +17% | +$46.2K | ﹤0.01% | 1046 |
|
|
2020
Q4 | $199K | Buy |
+29,860
| New | +$199K | ﹤0.01% | 1099 |
|
|
2018
Q2 | – | Sell |
-600
| Closed | -$4K | – | 1031 |
|
|
2018
Q1 | $4K | Hold |
600
| – | – | ﹤0.01% | 1001 |
|
|
2017
Q4 | $4K | Buy |
600
+200
| +50% | +$1.33K | ﹤0.01% | 1020 |
|
|
2017
Q3 | $4K | Buy |
+400
| New | +$4K | ﹤0.01% | 935 |
|
|
2015
Q1 | – | Sell |
-1,040
| Closed | -$17K | – | 1120 |
|
|
2014
Q4 | $17K | Hold |
1,040
| – | – | ﹤0.01% | 1051 |
|
|
2014
Q3 | $14K | Buy |
+1,040
| New | +$14K | ﹤0.01% | 965 |
|